Aster DM Healthcare Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- ✓Low debt relative to equity (D/E 0.5x)
Concerns
- ✗Premium to sector peers (P/E 175x vs industry 54.4x)
- ✗High premium to book value (P/B 8.2x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,944 | ₹4.6L Cr | 37.3 | 5.59 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹7,388 | ₹1.9L Cr | 73.4 | 11.71 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹5,040 | ₹1.6L Cr | 73.6 | 20.32 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,939 | ₹1.3L Cr | 64.9 | 13.56 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,416 | ₹1.1L Cr | 30.1 | 3.32 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,123 | ₹1.1L Cr | 21 | 4.17 | 21.2 | 21.1 | 0.38 |
| LUPIN Lupin Limited | ₹2,405 | ₹1.1L Cr | 19.6 | 4.9 | 28.7 | 29.9 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
ASTERDM · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 41.88% | 41.88% | 41.88% | 41.88% | 41.88% | 41.89% |
| FII | 41.00% | 33.48% | 27.08% | 23.86% | 22.62% | 21.66% |
| DII | 7.15% | 13.70% | 16.35% | 20.91% | 22.91% | 24.58% |
| Public | 9.61% | 10.59% | 14.38% | 13.05% | 12.30% | 11.60% |
| Others | 0.37% | 0.35% | 0.32% | 0.30% | 0.28% | 0.26% |
Corporate Events
Interim Dividend - Rs 3 Per Share
Record: 2 Apr 2026
Dividend - Re 1 Per Share
Interim Dividend - Rs 4 Per Share
Annual General Meeting/Dividend - Rs 2 Per Share
Special Dividend - Rs 118 Per Share
Latest News
All news →Aster DM Healthcare sets record date post-NCLT approval
*Aster DM Healthcare sets record date post-NCLT approval*. The company has noted the NCLT order and fixed a record date for the amalgamation scheme. The move paves the way for the proposed corporate restructuring. Shareholders will be eligible for benefits based on the record date. 📊 *STOCKS:* ASTERDM | 🏢 *SECTOR:* Healthcare | #MEDIUMIMPACT #Amalgamation
Aster DM Healthcare to acquire healthcare assets
*Aster DM Healthcare to acquire healthcare assets.* The company announced a strategic acquisition to expand its medical network. Deal size and specific assets remain undisclosed. This move aims to strengthen its presence in key markets. 📊 *STOCKS:* ASTERDM | 🏢 *SECTOR:* Healthcare | #MEDIUMIMPACT #Acquisition
Aster DM Healthcare appoints Varun Khanna as MD & Group CEO
*Aster DM Healthcare appoints Varun Khanna as MD & Group CEO following merger.* The appointment comes after the completion of the merger with Devyani. Varun Khanna brings over **20 years** of healthcare experience. This leadership shift aims to strengthen integration and drive future growth. 📊 *STOCKS:* ASTERDM | 🏢 *SECTOR:* Healthcare | #HIGHIMPACT #LeadershipChange
Aster DM merger with QCIL creates top 3 hospital chain
*Aster DM merger with QCIL creates top 3 hospital chain* — The combined entity will rank among India's top 3 hospital chains by scale and revenue, boosting market presence. Integration expected to unlock **₹1,500 crore** in synergies over 3 years. National footprint expands to **over 12,000 beds** across **150+ facilities**. 📊 *STOCKS:* ASTERDM, QCIL | 🏢 *SECTOR:* Healthcare | #HIGHIMPACT #Merger
Aster DM Healthcare Q4 profits surge on merger boost
*Aster DM Healthcare Q4 profits surge on merger boost* — The company reported strong Q4 earnings driven by its recent merger, with consolidated revenue rising **28% YoY** to **₹1,450 crore** and EBITDA margin expanding to **24.3%**. However, analysts are questioning its stretched valuation amid competitive pressures. A review by Whalesbook highlights integration risks despite robust top-line growth. 📊 *STOCKS:* ASTERDM | 🏢 *SECTOR:* Healthcare | #HIGHIMPACT #Earnings
Aster DM Healthcare completes merger with Quality Care India
*Aster DM Healthcare completes merger with Quality Care India* Aster DM Healthcare announced the successful completion of its merger with Quality Care India Limited, effective July 02, 2026. The consolidation aims to strengthen Aster’s hospital network and enhance operational scale. This integration is expected to improve cost efficiencies and expand patient reach across key markets. 📊 *STOCKS:* ASTERDM | 🏢 *SECTOR:* Healthcare | #MEDIUMIMPACT #Merger
Aster DM and Quality Care merger complete.
*Aster DM and Quality Care merger complete.* Combined entity has started operations, creating one of India’s largest healthcare providers. The merger is expected to unlock synergies and expand reach across hospitals and clinics. Integration may lead to cost savings and improved margins over time. 📊 *STOCKS:* ASTERDM, QUALITY | 🏢 *SECTOR:* Healthcare | #MEDIUMIMPACT #Merger
Aster DM launches merged healthcare ops with 10,000+ beds
*Aster DM launches merged healthcare ops with 10,000+ beds*. The integration of Aster DM Healthcare and Quality Care establishes India’s largest private healthcare network with **over 10,000 beds** across urban and rural centers. This move strengthens its pan-India presence and operational scale. The unified entity aims to boost efficiency and expand access to affordable healthcare. 📊 *STOCKS:* ASTERDM | 🏢 *SECTOR:* Healthcare | #MEDIUMIMPACT #Healthcare
Aster DM Healthcare starts ops post-merger with Quality Care India
*Aster DM Healthcare starts ops post-merger with Quality Care India.* The combined entity has commenced operations following the completion of the merger. This integration aims to strengthen Aster DM’s healthcare delivery network in India. The move is expected to enhance operational synergies and market presence. 📊 *STOCKS:* ASTERDM | 🏢 *SECTOR:* Healthcare | #MEDIUMIMPACT #Merger
NCLT approves Aster DM-HealthCare merger, QCIL to dissolve
*NCLT approves Aster DM-HealthCare merger, QCIL to dissolve*. The National Company Law Tribunal has cleared the merger between Aster DM Healthcare and Quality Care India. QCIL will be dissolved after the filing process. The move consolidates Aster DM’s position in India’s healthcare sector. 📊 *STOCKS:* QCIL, ASTERDM | 🏢 *SECTOR:* Corporate | #MEDIUMIMPACT #Merger
Financials
Quarterly Results
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1.2K Cr ▼0.3% | ₹1.2K Cr ▼0.9% | ₹1.2K Cr ▲11.0% | ₹1.1K Cr ▲7.8% | ₹1.0K Cr ▼4.8% | ₹1.1K Cr ▼3.3% | ₹1.1K Cr ▲8.4% | ₹1.0K Cr |
| Op. Profit | ₹224 Cr ▲10.9% | ₹202 Cr ▼14.4% | ₹236 Cr ▲16.8% | ₹202 Cr ▲11.0% | ₹182 Cr ▼2.2% | ₹186 Cr ▼14.3% | ₹217 Cr ▲34.8% | ₹161 Cr |
| OPM | 19.0% ▲11.8% | 17.0% ▼15.0% | 20.0% ▲5.3% | 19.0% ▲5.6% | 18.0% ▲0.0% | 18.0% ▼10.0% | 20.0% ▲25.0% | 16.0% |
| Net Profit | ₹154 Cr ▲161.0% | ₹59 Cr ▼51.2% | ₹121 Cr ▲28.7% | ₹94 Cr ▲9.3% | ₹86 Cr ▲34.4% | ₹64 Cr ▼39.6% | ₹106 Cr ▼97.9% | ₹5.2K Cr |
| EPS (₹) | 2.71 ▲168.3% | 1.01 ▼52.4% | 2.12 ▲28.5% | 1.65 ▲4.4% | 1.58 ▲38.6% | 1.14 ▼41.2% | 1.94 ▼98.1% | 103 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹4.6K Cr ▲12.2% | ₹4.1K Cr ▲11.9% | ₹3.7K Cr ▲23.5% | ₹3.0K Cr ▼70.8% | ₹10.3K Cr ▲19.1% | ₹8.6K Cr ▼0.5% | ₹8.7K Cr ▲8.7% | ₹8.0K Cr ▲18.5% | ₹6.7K Cr ▲13.3% | ₹5.9K Cr |
| Expenses | ₹3.8K Cr ▲11.7% | ₹3.4K Cr ▲8.3% | ₹3.1K Cr ▲22.7% | ₹2.5K Cr ▼70.8% | ₹8.7K Cr ▲16.2% | ₹7.5K Cr ▲4.4% | ₹7.2K Cr ▲4.4% | ₹6.9K Cr ▲13.1% | ₹6.1K Cr ▲9.1% | ₹5.6K Cr |
| Op. Profit | ₹864 Cr ▲14.6% | ₹754 Cr ▲31.1% | ₹575 Cr ▲28.6% | ₹447 Cr ▼70.8% | ₹1.5K Cr ▲39.0% | ₹1.1K Cr ▼24.7% | ₹1.5K Cr ▲36.0% | ₹1.1K Cr ▲70.4% | ₹632 Cr ▲81.1% | ₹349 Cr |
| OPM | 19.0% ▲5.6% | 18.0% ▲12.5% | 16.0% ▲6.7% | 15.0% ▲0.0% | 15.0% ▲15.4% | 13.0% ▼23.5% | 17.0% ▲21.4% | 14.0% ▲55.6% | 9.0% ▲50.0% | 6.0% |
| Other Income | ₹93 Cr ▼98.2% | ₹5.2K Cr ▲16053.1% | ₹32 Cr ▼90.9% | ₹353 Cr ▲592.2% | ₹51 Cr ▼3.8% | ₹53 Cr ▲133.5% | ₹-158 Cr ▼1.9% | ₹-155 Cr ▼187.6% | ₹177 Cr ▼60.9% | ₹453 Cr |
| Interest | ₹123 Cr ▼7.5% | ₹133 Cr ▲11.8% | ₹119 Cr ▲24.0% | ₹96 Cr ▼68.7% | ₹307 Cr ▼8.1% | ₹334 Cr ▼14.6% | ₹391 Cr ▲90.7% | ₹205 Cr ▲0.5% | ₹204 Cr ▼45.0% | ₹371 Cr |
| Depreciation | ₹264 Cr ▲6.0% | ₹249 Cr ▲13.2% | ₹220 Cr ▲14.6% | ₹192 Cr ▼70.0% | ₹641 Cr ▲3.7% | ₹618 Cr ▲5.5% | ₹586 Cr ▲91.5% | ₹306 Cr ▲2.7% | ₹298 Cr ▼7.5% | ₹322 Cr |
| PBT | ₹570 Cr ▼89.7% | ₹5.5K Cr ▲1967.9% | ₹268 Cr ▼47.6% | ₹511 Cr ▼19.8% | ₹637 Cr ▲210.7% | ₹205 Cr ▼37.9% | ₹330 Cr ▼19.5% | ₹410 Cr ▲33.1% | ₹308 Cr ▲185.2% | ₹108 Cr |
| Tax % | 25.0% ▲1150.0% | 2.0% ▼90.5% | 21.0% ▲200.0% | 7.0% ▲16.7% | 6.0% ▼53.8% | 13.0% ▲160.0% | 5.0% ▼50.0% | 10.0% ▲25.0% | 8.0% ▼20.0% | 10.0% |
| Net Profit | ₹427 Cr ▼92.1% | ₹5.4K Cr ▲2450.9% | ₹212 Cr ▼55.4% | ₹475 Cr ▼21.0% | ₹601 Cr ▲237.6% | ₹178 Cr ▼43.5% | ₹315 Cr ▼14.2% | ₹367 Cr ▲30.1% | ₹282 Cr ▲187.8% | ₹98 Cr |
| EPS (₹) | 7.49 ▼93.0% | 107.66 ▲4056.8% | 2.59 ▼69.6% | 8.51 ▼19.2% | 10.53 ▲255.7% | 2.96 ▼46.6% | 5.54 ▼15.9% | 6.59 ▲23.9% | 5.32 ▲111.1% | 2.52 |
| Div Payout | 40.0% ▲700.0% | 5.0% ▼99.9% | 4637.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||||
| Equity Capital | ₹518 Cr ▲3.6% | ₹500 Cr ▲0.0% | ₹500 Cr ▲0.0% | ₹500 Cr ▲0.0% | ₹500 Cr ▲0.6% | ₹497 Cr ▲0.0% | ₹497 Cr ▼1.6% | ₹505 Cr ▲0.0% | ₹505 Cr ▲25.3% | ₹403 Cr |
| Reserves | ₹4.1K Cr ▲58.9% | ₹2.6K Cr ▼30.7% | ₹3.7K Cr ▲3.1% | ₹3.6K Cr ▲16.0% | ₹3.1K Cr ▲7.1% | ₹2.9K Cr ▲3.6% | ₹2.8K Cr ▲2.4% | ₹2.7K Cr ▲16.4% | ₹2.3K Cr ▲58.1% | ₹1.5K Cr |
| Borrowings | ₹2.2K Cr ▼7.2% | ₹2.4K Cr ▲36.1% | ₹1.8K Cr ▼71.1% | ₹6.1K Cr ▲15.0% | ₹5.3K Cr ▲10.0% | ₹4.8K Cr ▼14.3% | ₹5.6K Cr ▲101.0% | ₹2.8K Cr ▲18.5% | ₹2.4K Cr ▼14.7% | ₹2.8K Cr |
| Other Liabilities | ₹1.3K Cr ▲14.0% | ₹1.2K Cr ▼90.4% | ₹12.0K Cr ▲156.9% | ₹4.7K Cr ▲28.0% | ₹3.7K Cr ▲6.3% | ₹3.4K Cr ▼2.4% | ₹3.5K Cr ▲20.6% | ₹2.9K Cr ▲27.4% | ₹2.3K Cr ▲5.8% | ₹2.2K Cr |
| Total Liabilities | ₹8.1K Cr ▲22.9% | ₹6.6K Cr ▼63.3% | ₹18.0K Cr ▲21.2% | ₹14.8K Cr ▲18.5% | ₹12.5K Cr ▲7.8% | ₹11.6K Cr ▼6.3% | ₹12.4K Cr ▲38.9% | ₹8.9K Cr ▲19.4% | ₹7.5K Cr ▲9.9% | ₹6.8K Cr |
| Assets | ||||||||||
| Fixed Assets | ₹4.2K Cr ▲8.4% | ₹3.9K Cr ▲23.5% | ₹3.2K Cr ▼64.9% | ₹9.1K Cr ▲29.1% | ₹7.0K Cr ▲3.9% | ₹6.7K Cr ▼5.3% | ₹7.1K Cr ▲66.1% | ₹4.3K Cr ▲14.7% | ₹3.7K Cr ▲6.2% | ₹3.5K Cr |
| CWIP | ₹413 Cr ▲41.0% | ₹293 Cr ▲72.4% | ₹170 Cr ▼39.1% | ₹279 Cr ▼72.0% | ₹998 Cr ▲6.9% | ₹934 Cr ▲26.9% | ₹736 Cr ▲33.8% | ₹550 Cr ▲36.8% | ₹402 Cr ▲38.6% | ₹290 Cr |
| Investments | ₹1.2K Cr ▲376.3% | ₹245 Cr ▲1341.2% | ₹17 Cr ▼78.8% | ₹80 Cr ▲77.8% | ₹45 Cr ▼28.6% | ₹63 Cr ▲85.3% | ₹34 Cr ▲54.5% | ₹22 Cr ▼42.1% | ₹38 Cr ▲18.8% | ₹32 Cr |
| Other Assets | ₹2.3K Cr ▲6.6% | ₹2.1K Cr ▼85.3% | ₹14.6K Cr ▲169.5% | ₹5.4K Cr ▲21.4% | ₹4.5K Cr ▲15.4% | ₹3.9K Cr ▼14.1% | ₹4.5K Cr ▲10.9% | ₹4.1K Cr ▲23.2% | ₹3.3K Cr ▲11.5% | ₹3.0K Cr |
| Total Assets | ₹8.1K Cr ▲22.9% | ₹6.6K Cr ▼63.3% | ₹18.0K Cr ▲21.2% | ₹14.8K Cr ▲18.5% | ₹12.5K Cr ▲7.8% | ₹11.6K Cr ▼6.3% | ₹12.4K Cr ▲38.9% | ₹8.9K Cr ▲19.4% | ₹7.5K Cr ▲9.9% | ₹6.8K Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹656 Cr ▲54.4% | ₹425 Cr ▲169.0% | ₹158 Cr ▼91.4% | ₹1.8K Cr ▲39.6% | ₹1.3K Cr ▼16.3% | ₹1.6K Cr ▲28.3% | ₹1.2K Cr ▲103.5% | ₹601 Cr ▲11.9% | ₹537 Cr ▲48.8% | ₹361 Cr |
| Investing CF | ₹-288 Cr ▼104.8% | ₹6.0K Cr ▲785.1% | ₹-878 Cr ▲7.7% | ₹-951 Cr ▼68.9% | ₹-563 Cr ▼69.1% | ₹-333 Cr ▲49.4% | ₹-658 Cr ▲6.3% | ₹-702 Cr ▼34.5% | ₹-522 Cr ▲54.0% | ₹-1.1K Cr |
| Financing CF | ₹-304 Cr ▲95.2% | ₹-6.4K Cr ▼703.8% | ₹1.1K Cr ▲228.9% | ₹-817 Cr ▼19.1% | ₹-686 Cr ▲38.5% | ₹-1.1K Cr ▼65.3% | ₹-675 Cr ▼603.7% | ₹134 Cr ▲191.3% | ₹46 Cr ▼93.0% | ₹654 Cr |
| Net Cash Flow | ₹63 Cr ▼23.2% | ₹82 Cr ▼75.3% | ₹332 Cr ▲403.0% | ₹66 Cr ▲1.5% | ₹65 Cr ▼45.8% | ₹120 Cr ▲209.1% | ₹-110 Cr ▼433.3% | ₹33 Cr ▼45.9% | ₹61 Cr ▲150.0% | ₹-122 Cr |
| Free Cash Flow | ₹179 Cr ▲155.7% | ₹70 Cr ▲111.6% | ₹-601 Cr ▼160.4% | ₹995 Cr ▲29.2% | ₹770 Cr ▼34.9% | ₹1.2K Cr ▲65.5% | ₹715 Cr ▲1017.2% | ₹64 Cr ▲178.3% | ₹23 Cr ▲104.1% | ₹-565 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 24d ▲4.3% | 23d ▲0.0% | 23d ▼91.9% | 285d ▲295.8% | 72d ▼16.3% | 86d ▼14.0% | 100d ▲7.5% | 93d ▲10.7% | 84d ▲6.3% | 79d |
| Inventory Days | 32d ▼11.1% | 36d ▼18.2% | 44d ▼92.8% | 612d ▲374.4% | 129d ▲5.7% | 122d ▼11.6% | 138d ▲25.5% | 110d ▼0.9% | 111d ▲8.8% | 102d |
| Days Payable | 168d ▲1.2% | 166d ▼9.3% | 183d ▼86.9% | 1400d ▲424.3% | 267d ▼7.9% | 290d ▼4.3% | 303d ▲98.0% | 153d ▲2.0% | 150d ▼0.7% | 151d |
| Cash Conv. Cycle | -112d ▼4.7% | -107d ▲7.8% | -116d ▲76.9% | -503d ▼662.1% | -66d ▲20.5% | -83d ▼27.7% | -65d ▼230.0% | 50d ▲11.1% | 45d ▲50.0% | 30d |
| Working Capital Days | -28d ▲12.5% | -32d ▼111.8% | 272d ▲1395.2% | -21d ▼520.0% | 5d ▲0.0% | 5d ▼37.5% | 8d ▼71.4% | 28d ▼52.5% | 59d ▲883.3% | 6d |
| ROCE | 11.0% ▲0.0% | 11.0% ▲175.0% | 4.0% ▲33.3% | 3.0% ▼70.0% | 10.0% ▲66.7% | 6.0% ▼50.0% | 12.0% ▼7.7% | 13.0% ▲85.7% | 7.0% ▲600.0% | 1.0% |
Source: Screener.in · Lower days = better efficiency
About Aster DM Healthcare Limited
Aster DM Healthcare Limited is one of the largest integrated private healthcare service providers operating in GCC (Gulf Cooperation Council) countries and an emerging player in India. With an inherent emphasis on clinical excellence, it is one of the few entities in the world with a strong presence across primary, secondary, tertiary and quaternary healthcare. [1]
Healthcare · Healthcare Services